Background The immune suppression mechanisms in pancreatic ductal adenocarcinoma (PDAC) remain unknown, but preclinical ...

Cystic fibrosis (CF) is a life-threatening genetic disease affecting multiple organ systems, with pancreatic dysfunction ...

The model is the first of its kind to use multiple types of imaging and language-based data to assess a cancer patient's ...

In early 2024, the World Health Organization predicted that by 2050 there will be more than 35 million new cancer cases ...

(Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced ...

The CDE of China's NMPA has granted BTD to Innovent Biologics' IBI343 as a monotherapy treatment for CLDN18.2-positive PDAC ...

Researchers from the University of Michigan have developed a way of detecting circulating tumor cells in the bloodstream of ...

A recent double-blinded, peer-reviewed analysis published in Cancer Letters revealed that the experimental test correctly identified 71% of pancreatic cancer samples in the lab compared to only 44 ...